Learning Objectives:

  1.  Learn about the BRAF mutation and its molecular effects
  2.  Learn how having a BRAF mutation affects patient prognosis with standard of care colorectal cancer therapy
  3.  Look at therapeutic efforts to target BRAF mutation in colorectal cancer




  1. Review the epidemiology, prognostic factors and genomic landscape in mesothelioma
  2. Discuss the role of homologous DNA recombination repair in the pathogenesis of mesothelioma
  3. Highlight the clinical implications of targeting the DNA repair pathway
Session date: 
11/27/2017 - 12:00pm to 1:00pm CST
University of Chicago Medicine
5841 South Maryland Avenue
MC2115, Conference Room E-215
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Brian Heiss, MD and Arpita Desai, MD